Skip to content

FDA.reportPublic FDA data

NDC RxNorm DailyMed Applications GUDID GMDN PMA PMN MAUDE Recalls

Search FDA.report

Home
Company
NANOSTRING TECHNOLOGIES

NANOSTRING TECHNOLOGIES

PMN#

PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
2013-09-06
NANOSTRING TECHNOLOGIES

FDA.report indexes public FDA datasets and legacy FDA.report records. Source data can change; verify critical regulatory decisions with the official FDA source.

Privacy Sitemap Robots Ads.txt